Health And Medicine
-
Vanderbilt, international collaborators discover treatment to slow neurodegenerative diseases
Warren Center for Neuroscience Drug Discovery lead researchers discover a therapy that may treat memory loss and slow the progression of Alzheimer’s disease. Read MoreNov 15, 2022
-
Basic Sciences celebrates Hispanic Heritage Month
The School of Medicine Basic Sciences hosted the inaugural Hispanic Heritage Month Conference and Workshop, “Unidos: Inclusivity for a Stronger Nation,” to celebrate Hispanic and Latinx scientists. Read MoreNov 10, 2022
-
Hawiger still blazing a trail in inflammation research
Vanderbilt research describes a new investigational peptide drug that can penetrate immune and nonimmune cells, and block inflammatory signaling in a preclinical model of atopic dermatitis — eczema. Read MoreNov 10, 2022
-
AstraZeneca lead scientist visits to discuss Vanderbilt collaboration in COVID antibody Evusheld development
The Vanderbilt Vaccine Center will host a campus-wide presentation by Mark Esser, AstraZeneca vice president and head of microbial sciences, about Evusheld, an antibody combination that combats SARS-CoV-2 developed at Vanderbilt University Medical Center. The talk will be on Thursday, Nov. 17, at 10 a.m. in Light Hall, Room 202. Read MoreNov 10, 2022
-
Basic Sciences Dean’s Lecture presented by renowned virologist
The School of Medicine Basic Sciences Dean’s Lecture featured renowned immunologist, virologist, and alumnus Dr. Barney S. Graham. In his talk, “Reflections on Pandemics and the Future of Medicine,” Graham discussed his early research experiences leading up to his seminal work on the first experimental COVID-19 vaccines, along with his observations on the pandemic and hopes for the future of medicine. Read MoreNov 9, 2022
-
Study finds Moderna’s COVID-19 vaccine safe and effective for young children
A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age. Read MoreNov 4, 2022
-
Study explores possible drug target for neurological problems
A team at Case Western Reserve University and Vanderbilt University Medical Center has determined with atomic-level precision how two established drugs bind to and alter the conformation of a cell membrane transporter protein called NKCC1, shutting down its activity. Read MoreNov 3, 2022
-
Health equity focus of Nov. 15 VUSN Dean’s Diversity Lecture
Vanderbilt alumna G. Rumay Alexander will present the Vanderbilt University School of Nursing Dean’s Diversity Lecture on Tuesday, Nov. 15. Alexander will discuss providing health equity despite inequitable structures and systems. Read MoreNov 1, 2022
-
Interdisciplinary partnership leads to Vanderbilt Climate, Energy and Health Equity lab
Vanderbilt School of Nursing nurses and a social scientist from the College of Arts and Science have launched the Climate, Energy and Health Equity Lab to mitigate health disparities related to climate change. Read MoreOct 31, 2022
-
Vanderbilt-Ancora partnership advances research for rare form of epilepsy
Research in the Weaver lab leads to discoveries that help secure partnership with Ancora Innovation LLC. “Vanderbilt is at the forefront of genetic research. By understanding the genetic causes of disease opens exciting new opportunities to develop drugs to treat them more effectively,” said Matt Nelson, vice president, genetics and genomics, 3DC at Deerfield Management. Read MoreOct 27, 2022
-
School of Nursing earns 2022 INSIGHT Into Diversity award
The Vanderbilt University School of Nursing has won a Health Professions Higher Education Excellence in Diversity Award from INSIGHT Into Diversity magazine. Read MoreOct 26, 2022
-
Antentor Hinton Jr. receives Chan Zuckerberg Initiative grant to increase representation in research
Antentor Hinton Jr., assistant professor of molecular physiology and biophysics in the School of Medicine Basic Sciences, has been awarded a $1.15 million, five-year grant from the Chan Zuckerberg Initiative to boost diversity in STEM research. Read MoreOct 20, 2022
-
Study sheds light on the development of inflammation, high blood pressure and resulting kidney damage.
Researchers at Vanderbilt University Medical Center have found that the change in a single letter of the genetic code promotes, in a mouse model, the development of inflammation, high blood pressure and resulting kidney damage. Read MoreOct 20, 2022
-
Watch: Lab-to-Table Conversation: ‘The Science of Circadian Rhythms and Daylight Saving Time’
How does daylight saving time impact our health? Join Lisa Monteggia, Barlow Family Director of the Vanderbilt Brain Institute and professor of pharmacology, and panelists as they explore how time changes affect our circadian rhythms. Read MoreOct 19, 2022
-
Vanderbilt’s Carpenter, Monteggia and Rathmell elected to National Academy of Medicine
Christopher Carpenter, Lisa M. Monteggia and W. Kimryn Rathmell have been elected to the National Academy of Medicine for their major contributions to the advancement of medical science, health care and public policy. Read MoreOct 17, 2022
-
Audrey Bowden receives NIH funding to develop point-of-care detection of jaundice in newborns
Audrey Bowden, Dorothy J. Wingfield Phillips Chancellor’s Faculty Fellow and associate professor of biomedical and electrical engineering, has won a grant from the National Institute of Biomedical Imaging and Bioengineering to develop a novel noninvasive smartphone-integrated device to provide accurate, point-of-care detection of jaundice in newborns of all skin tones. Read MoreOct 13, 2022
-
Vanderbilt’s Crowe receives the Building the Foundation Award from Research!America
Vanderbilt's James Crowe Jr., MD, has received the Building the Foundation Award from Research!America, a national biomedical research advocacy organization. Read MoreOct 6, 2022
-
Study finds that reducing intake of simple sugars improves GERD
A Vanderbilt study found that reducing dietary carbohydrates improved both symptoms and objective measurements of gastroesophageal reflux disease (GERD) in a randomized controlled trial. Read MoreOct 6, 2022
-
Quality Education Minorities Network, Vanderbilt University receive grant to host underrepresented minorities in STEM conference
The Quality Education for Minorities Network, in partnership with Vanderbilt University and other universities, has been awarded funding for a conference on supporting underrepresented minorities in STEM. Read MoreOct 5, 2022
-
Barney Graham, distinguished Vanderbilt alumnus and COVID-19 scientific leader, to speak Oct. 17
Barney S. Graham, PhD'91, chief architect for the first experimental COVID-19 vaccine, will give the School of Medicine Basic Sciences Dean’s Lecture on Oct. 17 and be presented with the 2021 Distinguished Alumnus Award by Chancellor Daniel Diermeier. Read MoreSep 29, 2022